<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299971-20-20-biolabs-selected-by-evexia-diagnostics-to-offer-onetest-for-cancer-through-evexia-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:31:00+00:00</news:publication_date>
        <news:title>20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299756-xenon-to-highlight-phase-3-x-tole2-long-term-data-for-azetukalner-in-focal-onset-seizures-at-2026-aan-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Xenon to Highlight Phase 3 X-TOLE2 &amp; Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299796-abeona-therapeutics-announces-appointment-of-keith-a-goldan-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299918-clover-health-empowers-members-to-take-charge-of-their-health-data-through-healthex-partnership</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a48a25b-b654-4d62-adb3-d1a776346264/small/clover-logo-green-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299951-integra-lifesciences-unveils-new-real-world-evidence-highlighting-primatrix-utilization</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/00cf1e29-7492-4f89-bab1-6691cf2253c4/medium/primatrix-dermal-scaffold.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299992-ss-innovations-to-host-smrsc-2026-in-new-delhi-india-from-april-9-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cef267e0-040f-4889-a706-cc4d0ae49e55/small/new-logo-april-23-2025-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300074-cormedix-to-participate-in-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>CorMedix to Participate in Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb/small/crmd-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300165-milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300233-cdt-notes-sarborg-publication-of-prism-framework-expanding-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>CDT Notes Sarborg Publication of PRISM Framework Expanding AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MjNiMmZlYjctZjk3NS00MWViLThkMjktZWUwZGQ1YzVkNzRjLTEyNzQxMDItMjAyNi0wNC0wNy1lbg==/tiny/CDT-Equity-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299831-biorestorative-therapies-announces-strategic-collaboration-with-203-creates-to-build-and-commercialize-biocosmeceutical-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:15:00+00:00</news:publication_date>
        <news:title>BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299713-nextcure-receives-fast-track-designation-for-sim0505-cdh6-adc-in-ovarian-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:05:00+00:00</news:publication_date>
        <news:title>NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300472-emergent-biosolutions-launches-new-narcan-nasal-spray-carrying-case-and-multipacks-alongside-college-campus-outreach-to-expand-opioid-overdose</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:05:00+00:00</news:publication_date>
        <news:title>Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3fcbfc65-93d7-475f-9f23-b47fbf2ab8ca/medium/narcan-nasal-spray-multipacks.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299511-evaxion-announces-last-patient-visit-in-one-year-extension-of-phase-2-trial-with-personalized-cancer-vaccine-evx-01</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299601-lyell-immunopharma-announces-participation-in-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fa4a7bb1-f8ea-45e7-ba51-37077689a4fb/small/lyell-branding-color-rgb-102918a-copy-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299705-inhibikase-therapeutics-announces-enrollment-of-first-patient-in-improve-pah-global-phase-3-study-of-ikt-001-in-the-treatment-of-pulmonary-arterial</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/32b8d8bc-ebf8-43c0-866a-6613b22263b1/small/ikt-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299752-amneal-announces-2-million-donation-to-support-patient-access-to-essential-medicines-during-parkinson-s-awareness-month</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299830-crispr-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299833-gatc-health-and-uc-irvine-announce-landmark-pnas-publication-validating-ai-platform-for-opioid-use-disorder-treatment</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>GATC Health and UC Irvine Announce Landmark PNAS Publication Validating AI-Platform for Opioid Use Disorder Treatment</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8252f5cc-6aca-4b39-b708-845c0ce98b86/small/color-logo-vector-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299835-solid-biosciences-to-participate-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Solid Biosciences to Participate at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299849-valitor-announces-oral-presentation-at-the-upcoming-association-for-research-in-vision-and-ophthalmology-arvo-2026-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299853-route-92-medical-announces-50-million-growth-financing</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Route 92 Medical Announces $50 Million Growth Financing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/526036da-ddbe-4a9a-9222-9570f7cd6544/small/r-rt92-logo-rbg0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299871-akebia-therapeutics-to-conduct-investor-meetings-at-the-raymond-james-2026-biotech-innovation-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299961-aclarion-highlights-growing-adoption-of-nociscan-at-the-london-clinic-with-new-physician-video</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300025-calidi-biotherapeutics-announces-speaker-presentation-at-asgct-conference-in-boston-on-may-14-2026-highlighting-the-redtail-platform-s-ability-to</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300073-corbus-pharmaceuticals-announces-broad-alignment-with-fda-on-registration-path-for-crb-701-in-second-line-hnscc-and-cervical-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300089-liquidia-corporation-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Liquidia Corporation to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f7659070-cc55-4e68-ae70-33013e7df72c/small/liquidia-new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300151-electrocore-announces-first-patient-enrollment-in-investigator-led-study-of-gammacore-nvns-for-ptsd</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300354-jupiter-neurosciences-appoints-kristopher-fishman-and-sanjiv-lal-to-nugevia-advisory-board</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300403-polyrizon-ltd-announces-3-5-million-registered-direct-offering-and-private-placement</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/N2M3NTE1MmItYWFmMi00MDNlLWE4MTItMWIxMDg4MWYwMTRlLTUwMDEyOTIyMy0yMDI2LTA0LTA3LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300175-artelo-biosciences-regains-compliance-with-nasdaq-listing-requirements</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:50:00+00:00</news:publication_date>
        <news:title>Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/460502d7-b0d3-43d8-a15a-5b2bb963bbbb/small/artelo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299627-marvel-biosciences-secures-financial-and-strategic-investment-with-5-horizon-ventures</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d49e32dc-88d9-4694-a3dd-6e663548e80d/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299632-anavex-life-sciences-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299759-everbright-health-announces-ai-enabled-platform-to-unlock-access-to-advanced-mental-health-interventions</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Everbright Health Announces AI-Enabled Platform to Unlock Access to Advanced Mental Health Interventions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2ce4a623-23ed-4e51-9115-db1f2526bcfc/small/everbrighthealth-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299841-plus-therapeutics-receives-ama-pla-code-for-cnside-csf-tumor-cell-enumeration-test-advancing-reimbursement-and-u-s-commercial-adoption</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904299993-cognition-therapeutics-to-present-at-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Cognition Therapeutics to Present at Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a14fd627-7ccb-45e2-95fe-792bbfb83231/small/2020-0227-cognition-logo-for-gnw-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300070-palvella-therapeutics-appoints-accomplished-commercial-leader-kent-taylor-as-senior-vice-president-of-sales</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300109-cervomed-to-provide-neflamapimod-clinical-program-update-and-participate-in-a-panel-on-biomarkers-at-2026-lewy-body-dementia-association-annual</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/332fd58e-5e2b-4c96-8eaf-719ac2e34f52/small/cervomed-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300157-nervgen-pharma-announces-successful-end-of-phase-2-meeting-and-fda-alignment-on-restore-a-phase-3-registrational-study-of-nvg-291-for-chronic</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904300328-weight-watchers-appoints-lisa-gavales-and-sue-gove-to-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290412-pluristyx-extends-patent-portfolio-in-universal-cell-therapy-with-new-u-s-patent-for-iact-stealth-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:09:00+00:00</news:publication_date>
        <news:title>Pluristyx Extends Patent Portfolio in Universal Cell Therapy with New U.S. Patent for iACT Stealth™ Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/22e38345-b052-4cc3-a4c3-556e798109f3/small/pluristyx-logo-blue-apr22-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290254-fennec-pharmaceuticals-announces-investigator-sponsored-study-to-be-conducted-by-university-of-arizona-cancer-center</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:03:00+00:00</news:publication_date>
        <news:title>Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290176-invivyd-launches-antibodies-for-any-body-in-partnership-with-world-champion-skier-lindsey-vonn-to-inspire-actions-that-help-support-immune-health</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:01:00+00:00</news:publication_date>
        <news:title>Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290028-ac-immune-announces-amendment-to-morphomer-tau-license-and-collaboration-agreement-with-lilly</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290055-mediwound-to-present-new-escharex-data-at-leading-wound-care-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>MediWound to Present New EscharEx® Data at Leading Wound Care Conferences </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290057-radiopharm-theranostics-and-siemens-healthineers-sign-clinical-supply-agreement-for-rad101-in-the-u-s</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/8e246920-183e-46a4-b13c-a3c9ec50ada9/small/radx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290245-sionna-therapeutics-to-participate-in-the-raymond-james-2026-biotech-innovation-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290255-soleo-health-relocates-denver-specialty-pharmacy-to-support-continued-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Soleo Health Relocates Denver Specialty Pharmacy to Support Continued Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b3c4bcdc-fa25-4f50-8b81-09f13e80a008/small/soleo-logo-1024-x-1024-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290282-breckenridge-distillery-introduces-honey-whiskey-crafted-with-rare-nigerian-goldswarm-honey-a-must-try-for-whiskey-enthusiasts</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cb623008-0c9a-49db-ab38-6e3062dd8bdb/medium/breckenridge-distillery-honey-whiskey.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290354-climb-bio-announces-fda-fast-track-designation-for-budoprutug-for-the-treatment-of-primary-membranous-nephropathy</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290361-skye-bioscience-presenting-at-glp-1-based-therapeutics-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290381-nurix-therapeutics-to-participate-in-upcoming-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Nurix Therapeutics to Participate in Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/65f50366-0a4e-4329-b0f5-f737c6145524/small/new-primary-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290410-fortrea-unveils-fortrea-intelligent-technology-to-help-sponsors-and-sites-run-smarter-more-integrated-trials</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9fbbe00b-8782-464e-83e6-5843c563884a/small/fortrea-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290597-neuronetics-comments-on-letter-from-pointillist-family-office</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Neuronetics Comments on Letter from Pointillist Family Office</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290600-okyo-pharma-announces-scientific-advisory-board-meeting-and-urcosimod-data-presentation-during-ascrs-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/23e4046d-dcf9-4dd1-945e-461e98a27d15/small/full-logo-okyo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290602-vantage-hemp-co-engages-acos-and-gpos-to-advance-participation-in-cms-cbd-pilot-program</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d38e4562-945b-4df7-8869-623c43be10f1/medium/inside-vantages-manufacturing-facility.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290206-ani-pharmaceuticals-announces-publication-of-new-day-clinical-trial-results-in-ophthalmology</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:50:00+00:00</news:publication_date>
        <news:title>ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904290397-bluejay-diagnostics-inc-announces-completion-of-624-patient-enrollments-in-symon-ii-pivotal-clinical-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:30:00+00:00</news:publication_date>
        <news:title>Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0d4a766-5115-448d-ba8a-d522100949f1/small/bjdx-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904280802-serina-therapeutics-to-present-at-the-5th-lnp-formulation-process-development-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>Serina Therapeutics to Present at the 5th LNP Formulation &amp; Process Development Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7f8e4304-8465-4d4d-a7e3-ebc4eae51f29/small/yellow-burts-blue-text-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904280810-ascellahealth-named-to-financial-times-americas-fastest-growing-companies-2026-list</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>AscellaHealth Named to Financial Times Americas’ Fastest Growing Companies 2026 List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5278c55f-330c-41a1-8446-d8b1a07bbc55/small/ah-logo-colornotag-4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904280821-greenwich-lifesciences-provides-update-on-patent-claims-potentially-doubling-gp2-market-potential</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904263002-oculis-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T08:00:00+00:00</news:publication_date>
        <news:title>Oculis to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904253341-sononeu-exits-stealth-as-key-part-of-us-government-funded-research-program-worth-up-to-41-3m-to-advance-sonogenetics-into-clinic</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T07:00:00+00:00</news:publication_date>
        <news:title>SonoNeu exits stealth as key part of US Government-funded research program worth up to $41.3m to advance sonogenetics into clinic</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/28b90f6b-ca31-4be4-92ca-1d1e341f55f3/small/sononeu-small-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904235360-press-release-sanofi-s-lunsekimig-met-primary-and-key-secondary-endpoints-in-phase-2-respiratory-studies-in-asthma-and-crswnp</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T05:00:00+00:00</news:publication_date>
        <news:title>Press Release:  Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904235375-communiqu-de-presse-le-lunsekimig-de-sanofi-a-atteint-les-crit-res-d-valuation-principal-et-secondaires-cl-s-dans-les-tudes-respiratoires-de-phase</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T05:00:00+00:00</news:publication_date>
        <news:title>Communiqué de presse: Le lunsekimig de Sanofi a atteint les critères d’évaluation principal et secondaires clés dans les études respiratoires de phase 2 dans l’asthme et la rhinosinusite chronique avec polypose nasale</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904203057-memogenesis-claims-evaluated-researching-the-latest-memo-genesis-formulation-facts</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T01:10:16+00:00</news:publication_date>
        <news:title>MemoGenesis Claims Evaluated: Researching the Latest Memo Genesis Formulation Facts</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/MemoGenesis.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904203030-ryoncil-continues-successful-first-year-launch-with-net-sales-of-us-30-3m-in-march-quarter</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T01:03:58+00:00</news:publication_date>
        <news:title>Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904187967-q1-2026-strong-revenue-growth-and-therapeutics-pipeline-advancement</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T23:37:15+00:00</news:publication_date>
        <news:title>Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904187944-organogenesis-achieves-primary-endpoint-in-randomized-controlled-trial-of-puraply-am</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T23:02:29+00:00</news:publication_date>
        <news:title>Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904174110-renovare-therapeutics-inc-announces-company-launch-and-collaboration-with-cu-boulder-awardee-of-up-to-33-5-million-in-arpa-h-funding-to-advance</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:59:37+00:00</news:publication_date>
        <news:title>Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of up to $33.5 Million in ARPA-H Funding to Advance Osteoarthritis Regenerative Therapies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OTA0OGZiNjgtYTYzNi00MDUzLTk4YmYtYTMwMzBjYjVjMmNmLTEzMjIzODItMjAyNi0wNC0wNi1lbg==/tiny/Renovare-Therapeutics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904173827-avicanna-announces-changes-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:30:00+00:00</news:publication_date>
        <news:title>Avicanna Announces Changes to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904173889-organogenesis-announces-successful-fda-meeting-and-plan-to-file-bla-for-renu-for-knee-osteoarthritis-pain</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:30:00+00:00</news:publication_date>
        <news:title>Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904167591-metabo-drops-claims-evaluated-recent-investigation-into-metabodrops-official-website-announcement</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T21:16:34+00:00</news:publication_date>
        <news:title>Metabo Drops Claims Evaluated: Recent Investigation Into MetaboDrops Official Website Announcement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Metabo-Drops.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904161943-neuronetics-announces-chief-financial-officer-transition</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:30:00+00:00</news:publication_date>
        <news:title>Neuronetics Announces Chief Financial Officer Transition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904162001-glyco-harmony-drops-claims-evaluated-explore-the-official-gluco-harmony-glycogen-support-website-facts</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:21:12+00:00</news:publication_date>
        <news:title>Glyco Harmony Drops Claims Evaluated: Explore the Official Gluco Harmony Glycogen Support Website Facts</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Glyco-Harmony-Drops.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904161867-silo-pharma-receives-european-patent-allowance-for-licensed-novel-ptsd-prevention-therapy</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:15:00+00:00</news:publication_date>
        <news:title>Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904161146-outset-medical-names-derick-elliott-as-executive-vice-president-of-commercial</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:05:00+00:00</news:publication_date>
        <news:title>Outset Medical Names Derick Elliott as Executive Vice President of Commercial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904161822-nanox-to-report-fourth-quarter-2025-financial-results-on-april-20-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:05:00+00:00</news:publication_date>
        <news:title>Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2/small/nano-logo-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904161913-immuneering-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:05:00+00:00</news:publication_date>
        <news:title>Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904161866-dianthus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:01:00+00:00</news:publication_date>
        <news:title>Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c9002285-2240-4dab-aced-77296f86a3fa/small/dianthus-logo-primary-full-color-cmyk-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904161983-ascendis-receives-orphan-drug-exclusivity-and-launches-yuviwel-navepegritide-in-the-united-states</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:01:00+00:00</news:publication_date>
        <news:title>Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904161906-cytokinetics-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T20:00:00+00:00</news:publication_date>
        <news:title>Cytokinetics to Participate in the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904149403-mistr-founder-tristan-schukraft-joins-the-producing-team-of-titanique</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T19:00:00+00:00</news:publication_date>
        <news:title>MISTR Founder Tristan Schukraft Joins the Producing Team of Titanique</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NjA1ZGExYWItMDMwMC00NGI5LTk1ZTItM2NjNmIzZWNjZmNjLTUwMDEzNDg1Ny0yMDI2LTA0LTA2LWVu/tiny/MISTR.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904149512-glucozen-claim-evaluated-highly-effective-blood-sugar-support-for-natural-glucose-harmony</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T18:40:44+00:00</news:publication_date>
        <news:title>GlucoZen Claim Evaluated: Highly-Effective Blood Sugar Support for Natural Glucose Harmony</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/GlucoZen-Drops.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904143857-global-validation-calibration-and-standardization-in-life-sciences-market-to-reach-3-9-billion-by-2030-fueled-by-regulatory-demands-and-digital</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T18:00:00+00:00</news:publication_date>
        <news:title>Global Validation, Calibration and Standardization in Life Sciences Market to Reach $3.9 Billion by 2030, Fueled by Regulatory Demands and Digital Transformation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904143771-wellspan-health-announces-president-ceo-roxanna-gapstur-s-planned-retirement</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T17:49:26+00:00</news:publication_date>
        <news:title>WellSpan Health announces President &amp; CEO Roxanna Gapstur’s planned retirement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NGE2MDdiZGQtMzEyMy00NmIxLWE0ZTUtM2JmODBmOTQyOTg1LTEyMjE1MzQtMjAyNi0wNC0wNi1lbg==/tiny/WellSpan-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904138873-dibs-ai-unveils-version-9-0-platform-suite-to-streamline-orthodontic-workflows</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T17:30:00+00:00</news:publication_date>
        <news:title>DIBS AI Unveils Version 9.0 Platform Suite to Streamline Orthodontic Workflows</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NzhmMTE3NzktZTQ1MS00OWY2LTkzMDgtZjAzYmU3OTY3YWI2LTEyMTI1MjAtMjAyNi0wNC0wNi1lbg==/tiny/OrthoSelect.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904129544-mistr-covers-florida-patients-as-adap-changes-create-gaps-in-hiv-treatment-access</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T16:14:44+00:00</news:publication_date>
        <news:title>MISTR Covers Florida Patients as ADAP Changes Create Gaps in HIV Treatment Access</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YTc5NzBiN2ItNDFmYy00MjgxLWJkOGYtMWVmZjk2ODRiM2JkLTUwMDEzNDg1Ny0yMDI2LTA0LTA2LWVu/tiny/MISTR.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904124434-biodesix-announces-aacr-2026-posters-and-presentations-highlighting-novel-diagnostic-test-discovery-pipeline-development</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T15:43:00+00:00</news:publication_date>
        <news:title>Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery &amp; Pipeline Development</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904119613-yuzu-health-raises-35-million-series-a-to-modernize-health-insurance-plan-infrastructure</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T15:00:00+00:00</news:publication_date>
        <news:title>Yuzu Health Raises $35 Million Series A to Modernize Health Insurance Plan Infrastructure</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZTNkMDYxNWQtZmVjYS00M2RlLWI0OWYtMzA2MGY0YjhlN2E2LTEzMjIzODUtMjAyNi0wNC0wNi1lbg==/tiny/Yuzu-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904119642-hairclub-launches-100-000-aderans-helping-hearts-fund-to-support-employees-facing-life-s-unexpected-hardships</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T15:00:00+00:00</news:publication_date>
        <news:title>HairClub Launches $100,000 Aderans Helping Hearts Fund to Support Employees Facing Life’s Unexpected Hardships</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDFmYjQwOTktMzE2MS00NTQ1LWI0ZDMtN2I4OWM2NDJjYzZjLTUwMDE1MzY4OS0yMDI2LTA0LTA2LWVu/tiny/HairClub.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904119717-celldex-therapeutics-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:53:52+00:00</news:publication_date>
        <news:title>Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904115336-sienna-senior-living-recognized-by-the-globe-and-mail-s-women-lead-here-benchmark</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:25:00+00:00</news:publication_date>
        <news:title>Sienna Senior Living recognized by The Globe and Mail’s Women Lead Here Benchmark</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ac969f39-0111-4903-8faa-0cdee524eb4e/small/sienna-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904111237-al-anon-family-groups-celebrates-75-years-of-recovery-providing-help-and-hope-to-families</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:00:00+00:00</news:publication_date>
        <news:title>Al‑Anon Family Groups Celebrates 75 Years of Recovery — Providing Help and Hope to Families</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/293e2cf1-ce41-48e5-a66c-8a69496d5d01/small/al-anon-family-groups-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904111343-adaptin-bio-shares-to-be-quoted-on-the-otcqb-under-ticker-symbol-aptn</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T14:00:00+00:00</news:publication_date>
        <news:title>Adaptin Bio Shares to be Quoted on the OTCQB Under Ticker Symbol APTN</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/89fb59f4-0171-4319-995d-70be0b36378b/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904107243-9-66-bn-gastroenterology-products-market-forecasts-to-2034-rising-aging-population-advancing-endoscopic-tech-and-expanding-healthcare-in</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:29:11+00:00</news:publication_date>
        <news:title>$9.66+ BN Gastroenterology Products Market Forecasts to 2034: Rising aging population, advancing endoscopic tech, and expanding healthcare in developing regions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904107250-zhengye-biotechnology-holding-limited-announces-implementation-of-dual-class-share-structure</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:25:00+00:00</news:publication_date>
        <news:title>Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9f44f819-7666-4ef0-b9e0-d50035c2a412/small/zybt-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904107196-curanex-highlights-patient-case-study-supporting-potential-of-phyto-n-in-cancer-cachexia-and-advanced-cancer-supportive-care</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:17:00+00:00</news:publication_date>
        <news:title>Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/29bc3de5-6a82-4a17-a165-6a79eef16d74/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103439-egg-medical-launches-eggnest-complete-flex-apron-free-protection-without-construction-downtime-or-disruption</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical Launches EggNest™ Complete Flex: Apron-Free Protection Without Construction, Downtime or Disruption</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/14f028e0-82c4-433b-a70a-84b9ad7c33c6/medium/eggnest-complete-flex.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103443-oncolytics-biotech-announces-type-c-fda-meeting-to-discuss-single-arm-registrational-pathway-for-pelareorep-in-anal-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4dca5efc-ee4e-4e0a-b42d-7b45369d75da/small/oncy-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103447-flare-therapeutics-announces-three-upcoming-poster-presentations-at-aacr-annual-meeting-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Flare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fbcb69a8-bb9a-4d13-b91e-c43f05ec2ee1/small/flaretx-logo-overlightbg-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103449-egg-medical-bringt-eggnest-complete-flex-auf-den-markt-schutz-ohne-sch-rzen-ohne-bauarbeiten-ausfallzeiten-oder-betriebsunterbrechungen</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical bringt EggNest™ Complete Flex auf den Markt: Schutz ohne Schürzen, ohne Bauarbeiten, Ausfallzeiten oder Betriebsunterbrechungen</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103453-egg-medical-lanza-eggnest-complete-flex-protecci-n-sin-delantal-sin-obras-ni-interrupciones</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical lanza EggNest™ Complete Flex: protección sin delantal, sin obras ni interrupciones</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103457-egg-medical-pr-sente-eggnest-complete-flex-une-protection-sans-tablier-sans-travaux-sans-interruption-de-service-ni-perturbation</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical présente EggNest™ Complete Flex : une protection sans tablier, sans travaux, sans interruption de service ni perturbation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103458-egg-medical-eggnest-complete-flex</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical משיקה את EggNest™ Complete Flex: הגנה ללא סינר, ללא בנייה, השבתה או שיבושים</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103462-egg-medical-meluncurkan-eggnest-complete-flex-perlindungan-bebas-apron-tanpa-pekerjaan-konstruksi-waktu-henti-atau-gangguan</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical Meluncurkan EggNest™ Complete Flex: Perlindungan Bebas Apron Tanpa Pekerjaan Konstruksi, Waktu Henti, atau Gangguan</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103469-eggnest-complete-flex</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>エッグ・メディカル、エッグネスト・コンプリート・フレックス (EggNest™ Complete Flex) を発売: 工事や稼働停止、業務中断なく、エプロン不要の防護を実現</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103472-egg-medical-eggnest-complete-flex</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical, 별도 공사나 다운타임 없이 납 앞치마 불필요한 방사선 보호 솔루션 ‘EggNest™ Complete Flex’ 출시</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103474-egg-medical-lancarkan-eggnest-complete-flex-perlindungan-tanpa-apron-tanpa-keperluan-kerja-pembinaan-masa-henti-atau-gangguan</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical Lancarkan EggNest™ Complete Flex: Perlindungan Tanpa Apron Tanpa Keperluan Kerja Pembinaan, Masa Henti atau Gangguan</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103475-egg-medical-lan-a-eggnest-complete-flex-prote-o-sem-avental-sem-constru-o-tempo-de-inatividade-ou-interrup-o</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical Lança EggNest™ Complete Flex: Proteção Sem Avental, Sem Construção, Tempo de Inatividade ou Interrupção</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103507-egg-medical-eggnest-complete-flex</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical เปิดตัว EggNest™ Complete Flex รุ่นป้องกันแบบไม่ต้องใช้เสื้อป้องกัน โดยไม่ต้องมีการก่อสร้าง ไม่ต้องหยุดการดำเนินงาน และไม่ขัดจังหวะการทำงา…</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103509-egg-medical-eggnest-complete-flex</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical 推出 EggNest™ Complete Flex：无需施工、停机或中断即可实现无铅衣防护</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103516-egg-medical-eggnest-complete-flex</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Egg Medical 推出 EggNest™ Complete Flex：免穿鉛圍的防護解決方案，免工程、不停機、無中斷</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a59b3b-1200-4803-9e32-91553d4bc51c/small/egg-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103575-stress-awareness-month-signals-shift-away-from-always-on-living</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T13:00:00+00:00</news:publication_date>
        <news:title>Stress Awareness Month Signals Shift Away from “Always-On” Living</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b847767e-6b43-48ae-ba24-0c320ae99e0f/medium/national-stress-awareness-month.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103552-onemednet-announces-strong-2025-financials-and-advances-ai-driven-irwd-powered-by-palantir-foundry-enabling-conversational-search-on-real-time</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:50:00+00:00</news:publication_date>
        <news:title>OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a356ae1d-a3c0-49e3-81b5-f19be76513d0/small/onemednet-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904103518-akari-therapeutics-announces-strategic-partnership-with-wuxi-xdc-to-advance-development-of-its-novel-adc-payload-targeting-rna-splicing</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:45:00+00:00</news:publication_date>
        <news:title>Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904100059-abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904100065-stablecoin-development-corporation-begins-trading-on-nyse-american-under-ticker-sdev</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:30:00+00:00</news:publication_date>
        <news:title>Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NDdlZTYyYTAtY2U1Ni00MzY2LWI2MTQtMDI5MDk0MDNhYjVkLTEwMjg2MTQtMjAyNi0wNC0wNi1lbg==/tiny/Stablecoin-Development-Corpora.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904100133-tomi-environmental-solutions-inc-announces-surge-in-steramist-adoption-across-compounding-pharmacy-industry-amid-tightening-regulatory-standards</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:30:00+00:00</news:publication_date>
        <news:title>TOMI Environmental Solutions, Inc. Announces Surge in SteraMist Adoption Across Compounding Pharmacy Industry Amid Tightening Regulatory Standards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904100107-stereotaxis-announces-fda-clearance-and-launch-of-synchrony-system</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:06:00+00:00</news:publication_date>
        <news:title>Stereotaxis Announces FDA Clearance and Launch of Synchrony System</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904100079-scienture-provides-annual-shareholder-update-outlining-significant-progress-and-strategic-priorities-for-the-year-ahead</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:05:00+00:00</news:publication_date>
        <news:title>Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/56382978-c242-4bdd-b491-e6966e27d4ed/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096500-geron-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096520-inspire-medical-systems-inc-to-report-first-quarter-2026-financial-results-on-may-4-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/194e83a5-3f7e-4805-88ce-da2e0ab594df/small/inspire-primary-logo-rgb-daylight-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096550-avalyn-appoints-jon-congleton-seasoned-biopharmaceutical-executive-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096557-verrica-pharmaceuticals-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096615-aveanna-healthcare-announces-second-annual-aveanna-cares-month-of-service</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Aveanna Healthcare Announces Second Annual Aveanna Cares Month of Service</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d3896f9e-a6a1-48c1-a8f7-d9ba5d7433d6/small/aveanna-healthcare-500x262-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096643-tenvie-therapeutics-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-tnv262-a-fully-cns-penetrant-nlrp3-inhibitor</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV262, a Fully CNS-Penetrant NLRP3 Inhibitor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/311d9377-979c-4384-9258-5b496e854edb/small/tenvie-logo-gradient-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096651-phathom-pharmaceuticals-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096655-praxis-precision-medicines-announces-positive-results-from-the-embrave-part-a-trial-of-elsunersen-in-patients-with-scn2a-early-onset-developmental-and</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096727-anna-autism-care-appoints-ariana-boutain-phd-bcba-d-as-chief-clinical-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>ANNA Autism Care Appoints Ariana Boutain, PhD, BCBA-D as Chief Clinical Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWMwMTNkZjMtYTQwYi00YjY3LTkzNjctOWU3ZGMyZTY3Y2ZiLTEzMjA4ODAtMjAyNi0wNC0wNi1lbg==/tiny/ANNA-HEALTH-INCORPORATED.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096753-new-locket-data-accepted-in-leading-electrophysiology-journal</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>New LockeT Data Accepted in Leading Electrophysiology Journal</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096759-extendicare-announces-timing-of-2026-first-quarter-results-and-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Extendicare Announces Timing of 2026 First Quarter Results and Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904096792-axe-compute-names-kyle-okamoto-president-adding-deep-infrastructure-systems-expertise-to-executive-team</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T12:00:00+00:00</news:publication_date>
        <news:title>Axe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive Team</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904092950-organogenesis-holdings-inc-to-report-first-quarter-of-fiscal-year-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:30:00+00:00</news:publication_date>
        <news:title>Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904092960-medicus-pharma-submits-optimized-phase-2-study-protocol-to-u-s-fda-for-teverelix-in-acute-urinary-retention</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:30:00+00:00</news:publication_date>
        <news:title>Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904092976-kraig-biocraft-laboratories-shatters-production-record-delivering-over-1-3-metric-tons-of-spider-silk-cocoons-in-a-single-month-a-5x-increase-over</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:05:00+00:00</news:publication_date>
        <news:title>Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bd9626d2-4b5e-4f55-8b54-c8300fa5bef5/medium/bam1-recombinant-spider-silk-cocoons.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089915-invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:01:00+00:00</news:publication_date>
        <news:title>Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089912-stipple-bio-emerges-from-stealth-with-oversubscribed-100-million-series-a-financing-to-advance-stp-100-into-early-clinical-studies-and-advance-a</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/96c458bd-cad2-4343-89d4-8c60bcfde0a5/small/stipple-no-name-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089917-biocryst-appoints-sandeep-m-menon-chief-research-and-development-officer</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089923-sagimet-biosciences-announces-poster-and-oral-presentations-at-the-fueling-mash-metabolic-drivers-and-inflammatory-crosstalk-keystone-symposium-and</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089924-immunocore-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089932-agios-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-april-29-at-8-00-a-m-et</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089955-opus-genetics-solidifies-leadership-position-in-gene-therapy-development-for-inherited-retinal-diseases-with-strategic-long-term-financing-by-oberland</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089957-nrx-pharmaceuticals-nasdaq-nrxp-announces-fda-labeling-alignment-for-nrx-s-preservative-free-ketamine-application</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089969-sharps-technology-reports-2025-year-end-results-and-highlights-continued-execution-of-solana-treasury-strategy</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7e8b9bfa-42f5-446c-932a-41a01c25ed6b/small/sharps-technology-nasdaq-stss-white-background-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904089975-neumora-therapeutics-to-participate-in-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T11:00:00+00:00</news:publication_date>
        <news:title>Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904086918-beacon-biosignals-upsizes-series-b-financing-to-over-97-million</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T10:30:00+00:00</news:publication_date>
        <news:title>Beacon Biosignals Upsizes Series B Financing to Over $97 Million</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0485bb01-d362-473e-8fae-a6cab3b804aa/small/beacon-logo-inline-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.mississippihealthcarereporter.com/article/904084259-profusa-expands-into-multi-billion-dollar-precision-diagnostics-market-with-30m-letter-of-intent-for-a-panomics-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Mississippi Healthcare Reporter</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-06T10:00:00+00:00</news:publication_date>
        <news:title>Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a8137a61-b858-48da-9e47-1f1bf8f6ddba/small/profusa-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
